세계의 대동맥류 시장 : 유형, 제품, 치료, 최종 용도별 예측(2025-2030년)

The Aortic Aneurysm Market was valued at USD 4.43 billion in 2023, expected to reach USD 4.79 billion in 2024, and is projected to grow at a CAGR of 8.65%, to USD 7.92 billion by 2030.

An aortic aneurysm is a localized enlargement of the aorta, the main artery carrying blood from the heart to the rest of the body. The market for its diagnosis and treatment is driven by the rising prevalence of cardiovascular diseases and an aging global population more susceptible to such conditions. Additionally, the increasing availability of advanced imaging technologies and surgical procedures, such as endovascular aneurysm repair (EVAR), expands the application and end-use scope across hospitals and specialty clinics. Market growth is primarily fueled by technological advancements in diagnostic tools, awareness programs about the importance of early detection, and government initiatives. However, the high costs associated with treatment, limited healthcare access in underprivileged regions, and the need for skilled healthcare professionals pose significant challenges. Key growth opportunities include the development of more cost-effective diagnostic solutions and minimally invasive surgical options, which would cater to a broader demographic while reducing recovery time and healthcare costs. Innovation lies at the intersection of biotechnology and data analytics, with research focused on genetic markers and artificial intelligence to predict aneurysm formation and progression more accurately. Businesses should explore partnerships with tech companies to develop AI-powered diagnostics and personalized treatment plans. However, navigating regulatory complexities is crucial, as compliance ensures safety and efficacy standards. Despite these hurdles, the market can benefit from expanding digital healthcare services, enabling remote monitoring and consultation for aortic aneurysm patients, thereby addressing some access issues. In conclusion, while the aortic aneurysm market faces limitations like high treatment costs and regulatory challenges, focused research and strategic collaborations in AI and biotechnology can pave the way for significant advancements. This approach not only promises better patient outcomes but also positions companies at the forefront of innovation in cardiovascular healthcare.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aortic Aneurysm Market

The Aortic Aneurysm Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of aortic aneurysms among aging population
  • Rise in awareness campaigns and routine screenings for at-risk populations
• Market Restraints
  • Rising incidences of product recalls
• Market Opportunities
  • Advances in medical imaging technology and minimally invasive surgical techniques
  • Collaborations between medical institutions
• Market Challenges
  • Concerns over complications during and after surgery of aortic aneurysms

Porter's Five Forces: A Strategic Tool for Navigating the Aortic Aneurysm Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aortic Aneurysm Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aortic Aneurysm Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aortic Aneurysm Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aortic Aneurysm Market

A detailed market share analysis in the Aortic Aneurysm Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aortic Aneurysm Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aortic Aneurysm Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aortic Aneurysm Market

A strategic analysis of the Aortic Aneurysm Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aortic Aneurysm Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Altura Medical Inc., Artivion, Inc., Bentley InnoMed GmbH, Bolton Medical, Inc., Boston Scientific Corporation, Cardinal Health company, Cook Medical Inc., CryoLife, Inc., Endologix Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Lemaitre Vascular Inc., LifeTech Scientific Corporation, LivaNova PLC, Lombard Medical, Inc., Medtronic PLC, MicroPort Scientific Corporation, Phenox GmbH, Terumo Corporation, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Aortic Aneurysm Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Abdominal Aortic Aneurysm and Thoracic Aortic Aneurysm.
• Based on Product, market is studied across Catheters and Stent Grafts.
• Based on Treatment, market is studied across Endovascular Aneurysm Repair and Open Surgical Repair.
• Based on End-use, market is studied across Ambulatory Surgery Centers, Clinic, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of aortic aneurysms among aging population
    • 5.1.1.2. Rise in awareness campaigns and routine screenings for at-risk populations
  • 5.1.2. Restraints
    • 5.1.2.1. Rising incidences of product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Advances in medical imaging technology and minimally invasive surgical techniques
    • 5.1.3.2. Collaborations between medical institutions
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns over complications during and after surgery of aortic aneurysms
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing cases of abdominal aortic aneurysm (AAA) found in older individuals with high blood pressure
  • 5.2.2. End-use: Evolving management and treatment of severe cases of aortic aneurysms in the hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Aortic Aneurysm Market, by Type

• 6.1. Introduction
• 6.2. Abdominal Aortic Aneurysm
• 6.3. Thoracic Aortic Aneurysm

7. Aortic Aneurysm Market, by Product

• 7.1. Introduction
• 7.2. Catheters
• 7.3. Stent Grafts

8. Aortic Aneurysm Market, by Treatment

• 8.1. Introduction
• 8.2. Endovascular Aneurysm Repair
• 8.3. Open Surgical Repair

9. Aortic Aneurysm Market, by End-use

• 9.1. Introduction
• 9.2. Ambulatory Surgery Centers
• 9.3. Clinic
• 9.4. Hospitals

10. Americas Aortic Aneurysm Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Aortic Aneurysm Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Aortic Aneurysm Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. UC Davis Health Initiates Regional First in Clinical Trial Using Innovative, Less Invasive Aortic Device
  • 13.3.2. FDA Approves New Gore Device for Advanced Aortic Aneurysm Treatment, Introducing the Excluder TAMBE Endoprosthesis
  • 13.3.3. Nectero Medical Launches Pivotal Clinical Trial for Innovative Aortic Aneurysm Treatment
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Altura Medical Inc.
• 3. Artivion, Inc.
• 4. Bentley InnoMed GmbH
• 5. Bolton Medical, Inc.
• 6. Boston Scientific Corporation
• 7. Cardinal Health company
• 8. Cook Medical Inc.
• 9. CryoLife, Inc.
• 10. Endologix Inc.
• 11. Johnson & Johnson Services, Inc.
• 12. Koninklijke Philips N.V.
• 13. Lemaitre Vascular Inc.
• 14. LifeTech Scientific Corporation
• 15. LivaNova PLC
• 16. Lombard Medical, Inc.
• 17. Medtronic PLC
• 18. MicroPort Scientific Corporation
• 19. Phenox GmbH
• 20. Terumo Corporation
• 21. W. L. Gore & Associates, Inc.